Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;43(1):3-11.
doi: 10.1017/ice.2021.322. Epub 2021 Jul 13.

Multisociety statement on coronavirus disease 2019 (COVID-19) vaccination as a condition of employment for healthcare personnel

David J Weber  1 , Jaffar A Al-Tawfiq  2   3   4 , Hilary M Babcock  5 , Kristina Bryant  6 , Marci Drees  7 , Ramy Elshaboury  8 , Katharine Essick  9 , Mohamad Fakih  10 , David K Henderson  11 , Waleed Javaid  12 , Diane Juffras  1 , Robin L P Jump  13   14 , Francesca Lee  15 , Anurag N Malani  16 , Trini A Mathew  17   18 , Rekha K Murthy  19 , David Nace  20 , Tara O'Shea  19 , Erica Pettigrew  1   21 , Ann Marie Pettis  22 , Joshua K Schaffzin  23 , Erica S Shenoy  8   24 , Julie Vaishampayan  25 , Zanthia Wiley  26 , Sharon B Wright  24   27 , Deborah Yokoe  28 , Heather Young  29
Affiliations

Multisociety statement on coronavirus disease 2019 (COVID-19) vaccination as a condition of employment for healthcare personnel

David J Weber et al. Infect Control Hosp Epidemiol. 2022 Jan.

Abstract

This consensus statement by the Society for Healthcare Epidemiology of America (SHEA) and the Society for Post-Acute and Long-Term Care Medicine (AMDA), the Association for Professionals in Epidemiology and Infection Control (APIC), the HIV Medicine Association (HIVMA), the Infectious Diseases Society of America (IDSA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP) recommends that coronavirus disease 2019 (COVID-19) vaccination should be a condition of employment for all healthcare personnel in facilities in the United States. Exemptions from this policy apply to those with medical contraindications to all COVID-19 vaccines available in the United States and other exemptions as specified by federal or state law. The consensus statement also supports COVID-19 vaccination of nonemployees functioning at a healthcare facility (eg, students, contract workers, volunteers, etc).

PubMed Disclaimer

Conflict of interest statement

The following disclosures are a reflection of what has been reported to SHEA. To provide thorough transparency, SHEA requires full disclosure of all relationships, regardless of relevancy to the guideline topic. Such relationships as potential conflicts of interest are evaluated in a review process that may include the Board of Trustees and Editor of Infection Control and Hospital Epidemiology. The assessment of disclosed relationships for possible conflicts of interest has been based on the relative weight of the financial relationship (ie, monetary amount) and the relevance of the relationship (ie, the degree to which an association might reasonably be interpreted by an independent observer as related to the topic or recommendation of consideration). D.J.W. is a consultant for Merck (vaccines), Pfizer (vaccines), PDI, Germitec, and UV Innovators. H.M.B. receives research funding with CDC Epicenter COVID-19 supplement: SHEPHERD COVID-19 Vaccine Effectiveness. K.B. is a clinical investigator on vaccine trials funded by Pfizer (pneumococcal vaccine and COVID-19 vaccines), Gilead, and Enanta, and receives honoraria from WebMed for a column in Pediatric News. R.E. is a coinvestigator on a study supported by Thermo Fisher examining the role of procalcitonin-supported antimicrobial stewardship efforts on antibiotic utilization. R.L.P.J. has research grants from Pfizer, Merck, and previously from Accelerate for projects related to bacterial infections, drug-resistant bacteria, and antibiotic stewardship, is on advisory boards for Pfizer for topics related to immunizations against against bacterial infections, and is on an advisory board for Pfizer with regard to their COVID-19 vaccine that was specific to the physical packaging and distribution of the vaccine (cold chain, dry ice, etc). F.L. is a clinical primary investigator for a CDC-funded small business development grant: Multiplex Detection of MDROs and Lower Intestinal Microbiome Disruption. A.N.M. has a research grant from CDC for the US Hospital Vaccine Effectiveness Network (grant no. 5 U01IP000974-05) to assess influenza vaccine effectiveness in preventing influenza-related hospitalizations. T.A.M. received an honorarium for a March 2021 grand rounds/CME lecture on COVID-19 vaccines delivered to faculty and trainees at a hospital in Michigan. Z.W. is the Emory University Hospital Midtown Site Lead Investigator, with research grants from Kinevant and the National Institutes of Health for DMID Protocol 20-0006: A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults. Z.W. is also a subinvestigator in the A Multicenter, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Acute Lung Injury or Acute Respiratory Distress Syndrome (ARDS) Secondary to Coronavirus Disease. D.Y. is included as an investigator on CDC (grant no. U54 CK000484) Prevention Epicenters IV but does not receive any personal financial support. H.Y. has a research grant from NIH for ACCT trials for COVID-19 treatment. All other authors report no conflicts of interest related to this article.

References

    1. CDC, NCIRD. v-safe COVID-19 vaccine pregnancy registry 2021. Centers for Disease Control and Prevention website. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafepregnancy.... Updated June 16, 2021. Accessed July 12, 2021.
    1. CDC, NCIRD. Pregnant and recently pregnant people at increased risk for severe ILLNESS from COVID-19. Centers for Disease Control and Prevention website. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/pregnan.... Updated June 10, 2021. Accessed June 2021.
    1. OSHA. Occupational exposure to COVID-19; Emergency Temporary Standard. June 21, 2021. ed. Federal Register. p. 32376-628.
    1. Office of Disease Prevention and Health Promotion. Topics & objectives: immunization and infectious diseases. HealthyPeople.gov website. https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-.... Published 2020. Accessed July 12, 2021.
    1. Coronavirus in the United States: latest map and case count. New York Times May 13, 2021.

Substances